Affinage

PPIH

Peptidyl-prolyl cis-trans isomerase H · UniProt O43447

Length
177 aa
Mass
19.2 kDa
Annotated
2026-06-10
6 papers in source corpus 3 papers cited in narrative 3 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 4/4 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PPIH (SnuCyp-20/CypH) is a nuclear cyclophilin that functions as a stable component of the U4/U6 snRNP, where it bridges its intrinsic enzymatic identity with a dedicated structural role in spliceosomal protein assembly (PMID:10713041, PMID:12907720). Its catalytic center superimposes on human cyclophilin A and confers peptidyl-prolyl cis/trans isomerase activity, but this catalytic pocket is dispensable for its defining interaction (PMID:10713041, PMID:12907720). Instead, a five-amino-acid insertion unique to PPIH creates an enlarged surface loop forming a hydrophobic cleft that constitutes a second, distinct protein-protein interaction surface, making PPIH the first small cyclophilin shown to carry two independent protein-binding faces (PMID:10713041, PMID:12907720). Through this arrangement PPIH binds the U4/U6 core protein PRPF4 (60K) in a bipartite manner, engaging the intrinsically disordered N-terminus of PRPF4 at two independent sites that each contribute to complex stability, with disruption requiring mutation of both (PMID:28935721). Beyond the structural and biochemical characterization of the PPIH-PRPF4 interaction, no further mechanistic detail has been characterized in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 3 steps
  1. 2000 High

    Established the structural basis of PPIH by showing its catalytic center matches cyclophilin A while revealing a unique insertion-generated surface feature, raising the question of whether this feature mediates spliceosomal partner binding.

    Evidence X-ray crystallography at 2.0 Å with molecular replacement and a PPIase activity assay

    PMID:10713041

    Open questions at the time
    • Did not directly demonstrate that the loop cleft mediates 60K/PRPF4 binding
    • No mutagenesis to separate catalytic from binding functions
  2. 2003 High

    Resolved whether catalytic activity drives partner association by showing that neither the PPIase activity nor the catalytic pocket is needed for stable 60K binding, which instead uses a distinct second interaction surface.

    Evidence Recombinant PPIase assays plus site-directed mutagenesis of the catalytic pocket and loop insertion with 60K binding assays

    PMID:12907720

    Open questions at the time
    • Did not define the molecular geometry of the second interaction site
    • Role of PPIase activity within the assembled snRNP not addressed
  3. 2017 Medium

    Defined the architecture of the PPIH-PRPF4 interaction as bipartite, engaging an intrinsically disordered PRPF4 N-terminus at two independently contributing sites required together for full complex stability.

    Evidence Recombinant protein complex formation and reciprocal point-mutation uncoupling of each binding site, with biophysical characterization of PRPF4 N-terminal disorder

    PMID:28935721

    Open questions at the time
    • No atomic-resolution structure of the bipartite complex
    • Single-lab characterization without orthogonal in-cell validation
    • Functional consequence of bipartite binding for spliceosome assembly untested

Open questions

Synthesis pass · forward-looking unresolved questions
  • The catalytic (PPIase) function of PPIH within the assembled spliceosome and its substrates remain unidentified.
  • No physiological PPIase substrate identified
  • Role of isomerase activity in U4/U6 snRNP function unknown
  • No cellular phenotype or disease link characterized in the corpus

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0016853 isomerase activity 2 GO:0060090 molecular adaptor activity 2
Pathway
R-HSA-8953854 Metabolism of RNA 2
Partners
Complex memberships
U4/U6 snRNP

Evidence

Reading pass · 3 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2000 Crystal structure of SnuCyp-20 (PPIH) determined at 2.0-Å resolution; the catalytic center superimposes with human cyclophilin A (hCypA), consistent with its observed peptidyl-prolyl cis/trans isomerase (PPIase) activity. An enlarged loop (alpha1-beta3), created by a five-amino-acid insertion unique to SnuCyp-20, forms a wide hydrophobic cleft proposed to mediate interaction with the U4/U6-60kD protein (PRPF4 ortholog). X-ray crystallography (2.0 Å, molecular replacement); PPIase activity assay The Journal of biological chemistry High 10713041
2003 Recombinant hCypH (PPIH) exhibits PPIase activity sharing the canonical catalytic pocket with other cyclophilins, but neither PPIase activity nor the catalytic pocket is required for stable binding to U4/U6 60K (PRPF4). Instead, a small insertion in a surface loop creates a second, distinct protein–protein interaction site that mediates specific, stable association with 60K, making PPIH the first small cyclophilin shown to have two protein–protein interaction surfaces. Recombinant protein expression and PPIase activity assay; site-directed mutagenesis of catalytic pocket and loop insertion; binding assays with 60K protein Nucleic acids research High 12907720
2017 PPIH interacts with the N-terminus of PRPF4 (60K ortholog) through two distinct binding sites (bipartite interaction); the PRPF4 N-terminal region is intrinsically disordered and does not adopt secondary structure upon PPIH binding. Mutations at both sites are necessary to fully disrupt the complex, indicating that both sites contribute independently to complex stability. Recombinant protein expression and purification; complex formation assay; mutational analysis (point mutations uncoupling each binding site); biophysical characterization of PRPF4 N-terminus disorder The Biochemical journal Medium 28935721

Source papers

Stage 0 corpus · 6 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2000 Crystal structure of the human U4/U6 small nuclear ribonucleoprotein particle-specific SnuCyp-20, a nuclear cyclophilin. The Journal of biological chemistry 26 10713041
2022 The CYP/20-HETE/GPR75 axis in hypertension. Advances in pharmacology (San Diego, Calif.) 24 35659370
2003 Two protein-protein interaction sites on the spliceosome-associated human cyclophilin CypH. Nucleic acids research 20 12907720
2024 PPIH acts as a potential predictive biomarker for patients with common solid tumors. BMC cancer 10 38834966
2017 The spliceosomal proteins PPIH and PRPF4 exhibit bi-partite binding. The Biochemical journal 9 28935721
2024 PPIH Expression Correlates with Tumor Aggressiveness and Immune Dysregulation in Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 1 39679070

Missed literature

Know a paper Affinage missed for PPIH? Flag it for the maintainers and the community.

No submissions yet.